P213 - A priori prediction of CYP3A victim drug-drug interaction of MK-1 and diltiazem using physiologically-based pharmacokinetic modeling (PBPK): qualification using clinical data
2014 ◽
Vol 63
◽
pp. 103-112
◽
2019 ◽
Vol 8
(7)
◽
pp. 489-499
◽
2017 ◽
Vol 104
(3)
◽
pp. 505-514
◽
2016 ◽
Vol 55
(11)
◽
pp. 1435-1445
◽
2016 ◽
Vol 5
(5)
◽
pp. 250-257
◽
2017 ◽
Vol 2
(4)
◽
pp. 233-245
◽
2017 ◽
Vol 102
(4)
◽
pp. 679-687
◽